TriStar Nashville Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2002
NCT00193401
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now

Alternative names

Institutional Review Board TriStar Nashville Market | TriStar Centennial Medical Center - HCA Healthcare

Active Ingredients

Drugs in Phase 2 Trials (1)

topotecan (hycamtin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lung Neoplasms (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1